The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to ICI-192605 TSA208865-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 TSA208904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 TSA208950-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 TSA209001-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 TSA209054-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 TSA209101-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 TSA209152-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 TSA209203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 TSA209237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 TSA209283-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 TSA209326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 TSA209372-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 TSA209418-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 TSF473193-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF473194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF473195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF473196-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF473197-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF473198-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF577635-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF577636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF577637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF577638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF577639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF473475-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF473472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF473473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF473474-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF473476-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF473477-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF577962-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF577963-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF577964-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF577965-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF577966-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF577967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF473767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF473764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF473765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF473766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF473768-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF473769-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF578299-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF578294-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF578295-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF578296-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF578297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF578298-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF474078-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF474079-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF474080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF474081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF474082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF474083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF578632-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF578628-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF578629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF578630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF578631-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF578633-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF474400-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF474399-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF474402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF474401-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF474403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF474404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF578964-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF578963-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF578965-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF578966-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF578967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF578968-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF474697-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF474700-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF474698-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF474699-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF474701-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF474702-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF579297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF579298-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF579299-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF579300-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF579301-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF579302-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF475011-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF475016-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF475012-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF475013-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF475014-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF475015-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF475321-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF475322-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF475323-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF475324-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF475325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF475326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF579628-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF579626-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF579627-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF579629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF579630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF579631-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF475610-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF475606-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF475607-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF475608-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF475609-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF475611-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF579958-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF579959-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF579955-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF579956-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF579957-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF579960-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF475909-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF475907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF475908-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF475911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF475910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF475912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF580290-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF580292-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF580291-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF580293-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF580294-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF580295-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF476199-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF476195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF476194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF476196-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF476197-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF476198-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF580629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF580625-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF580630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSF580626-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF580627-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF580628-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF476500-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF476499-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF476502-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF476501-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF476503-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF476504-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF476810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.37 µM for 24.0 h 1 subfactor(s) TSF476807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 10.0 µM for 24.0 h 1 subfactor(s) TSF476811-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.125 µM for 24.0 h 1 subfactor(s) TSF476808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 3.33 µM for 24.0 h 1 subfactor(s) TSF476809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 1.11 µM for 24.0 h 1 subfactor(s) TSF476812-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.04 µM for 24.0 h 1 subfactor(s) TSF580957-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.25 µM for 24.0 h 1 subfactor(s) TSF580955-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 2.22 µM for 24.0 h 1 subfactor(s) TSF580959-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.03 µM for 24.0 h 1 subfactor(s) TSF580956-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.74 µM for 24.0 h 1 subfactor(s) TSF580958-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.08 µM for 24.0 h 1 subfactor(s) TSF580960-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.01 µM for 24.0 h 1 subfactor(s) TSS473202-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 10.0 µM for 24.0 h TSS473203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 3.33 µM for 24.0 h TSS473204-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 1.11 µM for 24.0 h TSS473205-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.37 µM for 24.0 h TSS473206-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.125 µM for 24.0 h TSS473207-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.04 µM for 24.0 h TSS577645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 2.22 µM for 24.0 h TSS577646-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.74 µM for 24.0 h TSS577647-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.08 µM for 24.0 h TSS577648-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.03 µM for 24.0 h TSS577649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ICI-192605 0.01 µM for 24.0 h TSS473484-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.37 µM for 24.0 h TSS473481-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 10.0 µM for 24.0 h TSS473482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 3.33 µM for 24.0 h TSS473483-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 1.11 µM for 24.0 h TSS473485-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.125 µM for 24.0 h TSS473486-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.04 µM for 24.0 h TSS577972-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 2.22 µM for 24.0 h TSS577973-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.74 µM for 24.0 h TSS577974-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.25 µM for 24.0 h TSS577975-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.08 µM for 24.0 h TSS577976-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.03 µM for 24.0 h TSS577977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ICI-192605 0.01 µM for 24.0 h TSS473776-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.37 µM for 24.0 h TSS473773-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 10.0 µM for 24.0 h TSS473774-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 3.33 µM for 24.0 h TSS473775-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 1.11 µM for 24.0 h TSS473777-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.125 µM for 24.0 h TSS473778-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.04 µM for 24.0 h TSS578309-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.01 µM for 24.0 h TSS578304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 2.22 µM for 24.0 h TSS578305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.74 µM for 24.0 h TSS578306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.25 µM for 24.0 h TSS578307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.08 µM for 24.0 h TSS578308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ICI-192605 0.03 µM for 24.0 h TSS474087-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 10.0 µM for 24.0 h TSS474088-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 3.33 µM for 24.0 h TSS474089-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 1.11 µM for 24.0 h TSS474090-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.37 µM for 24.0 h TSS474091-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.125 µM for 24.0 h TSS474092-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.04 µM for 24.0 h TSS578642-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.03 µM for 24.0 h TSS578638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 2.22 µM for 24.0 h TSS578639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.74 µM for 24.0 h TSS578640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.25 µM for 24.0 h TSS578641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.08 µM for 24.0 h TSS578643-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to ICI-192605 0.01 µM for 24.0 h TSS474409-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 3.33 µM for 24.0 h TSS474408-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 10.0 µM for 24.0 h TSS474411-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.37 µM for 24.0 h TSS474410-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 1.11 µM for 24.0 h TSS474412-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.125 µM for 24.0 h TSS474413-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.04 µM for 24.0 h TSS578974-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.74 µM for 24.0 h TSS578973-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 2.22 µM for 24.0 h TSS578975-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.25 µM for 24.0 h TSS578976-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.08 µM for 24.0 h TSS578977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.03 µM for 24.0 h TSS578978-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to ICI-192605 0.01 µM for 24.0 h TSS474706-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 10.0 µM for 24.0 h TSS474709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.37 µM for 24.0 h TSS474707-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 3.33 µM for 24.0 h TSS474708-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 1.11 µM for 24.0 h TSS474710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.125 µM for 24.0 h TSS474711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.04 µM for 24.0 h TSS579307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 2.22 µM for 24.0 h TSS579308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.74 µM for 24.0 h TSS579309-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.25 µM for 24.0 h TSS579310-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.08 µM for 24.0 h TSS579311-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.03 µM for 24.0 h TSS579312-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ICI-192605 0.01 µM for 24.0 h TSS475020-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 10.0 µM for 24.0 h TSS475025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.04 µM for 24.0 h TSS475021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 3.33 µM for 24.0 h TSS475022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 1.11 µM for 24.0 h TSS475023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.37 µM for 24.0 h TSS475024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to ICI-192605 0.125 µM for 24.0 h TSS475330-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 10.0 µM for 24.0 h TSS475331-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 3.33 µM for 24.0 h TSS475332-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 1.11 µM for 24.0 h TSS475333-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.37 µM for 24.0 h TSS475334-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.125 µM for 24.0 h TSS475335-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.04 µM for 24.0 h TSS579638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.25 µM for 24.0 h TSS579636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 2.22 µM for 24.0 h TSS579637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.74 µM for 24.0 h TSS579639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.08 µM for 24.0 h TSS579640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.03 µM for 24.0 h TSS579641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to ICI-192605 0.01 µM for 24.0 h TSS475619-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.125 µM for 24.0 h TSS475615-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 10.0 µM for 24.0 h TSS475616-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 3.33 µM for 24.0 h TSS475617-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 1.11 µM for 24.0 h TSS475618-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.37 µM for 24.0 h TSS475620-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.04 µM for 24.0 h TSS579968-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.08 µM for 24.0 h TSS579969-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.03 µM for 24.0 h TSS579965-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 2.22 µM for 24.0 h TSS579966-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.74 µM for 24.0 h TSS579967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.25 µM for 24.0 h TSS579970-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ICI-192605 0.01 µM for 24.0 h TSS475918-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 1.11 µM for 24.0 h TSS475916-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 10.0 µM for 24.0 h TSS475917-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 3.33 µM for 24.0 h TSS475920-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.125 µM for 24.0 h TSS475919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.37 µM for 24.0 h TSS475921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.04 µM for 24.0 h TSS580300-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 2.22 µM for 24.0 h TSS580302-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.25 µM for 24.0 h TSS580301-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.74 µM for 24.0 h TSS580303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.08 µM for 24.0 h TSS580304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.03 µM for 24.0 h TSS580305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to ICI-192605 0.01 µM for 24.0 h TSS476208-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.04 µM for 24.0 h TSS476204-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 3.33 µM for 24.0 h TSS476203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 10.0 µM for 24.0 h TSS476205-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 1.11 µM for 24.0 h TSS476206-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.37 µM for 24.0 h TSS476207-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.125 µM for 24.0 h TSS580639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.03 µM for 24.0 h TSS580635-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 2.22 µM for 24.0 h TSS580640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.01 µM for 24.0 h TSS580636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.74 µM for 24.0 h TSS580637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.25 µM for 24.0 h TSS580638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ICI-192605 0.08 µM for 24.0 h TSS476509-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 3.33 µM for 24.0 h TSS476508-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 10.0 µM for 24.0 h TSS476511-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.37 µM for 24.0 h TSS476510-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 1.11 µM for 24.0 h TSS476512-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.125 µM for 24.0 h TSS476513-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to ICI-192605 0.04 µM for 24.0 h TSS476819-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.37 µM for 24.0 h TSS476816-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 10.0 µM for 24.0 h TSS476820-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.125 µM for 24.0 h TSS476817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 3.33 µM for 24.0 h TSS476818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 1.11 µM for 24.0 h TSS476821-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.04 µM for 24.0 h TSS580967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.25 µM for 24.0 h TSS580965-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 2.22 µM for 24.0 h TSS580969-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.03 µM for 24.0 h TSS580966-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.74 µM for 24.0 h TSS580968-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.08 µM for 24.0 h TSS580970-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to ICI-192605 0.01 µM for 24.0 h
TSP48967 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to ICI-192605
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided